HPLC purity
Reverse-phase HPLC with UV detection; ≥99% area-purity target on each production lot.
GLP-1 family · research-use
Retatrutide OEM supply.
Research use, worldwide.
Lyophilized retatrutide (triple GLP-1 / GIP / glucagon receptor research compound) for research labs and private-label brand evaluation worldwide. ≥99% HPLC purity target, batch-linked COA, HPLC chromatogram and MS identity record.
!
Research use — supplied as research peptides; buyers confirm local compliance
On 2026-04-30 the FDA proposed removing GLP-1 medications from the regulatory bulk-substance framework, with public comment open through 2026-06-29. Pending finalization, this compound is positioned for research and private-label brand evaluation worldwide. Read the GLP-1 2026 update →
Lot RET-10HPLC ≥ 99%MS confirmed5 / 10 / 15 / 20 mg
Vial illustrations reflect supplied lyophilized format. Lot codes are sample identifiers; production lots carry their own batch references.
| Compound | Retatrutide |
|---|---|
| CAS number | 2381089-83-2 |
| Class | Triple GLP-1 / GIP / glucagon receptor agonist (research) |
| Molecular weight | Confirmed on batch-linked COA for each production lot |
| Form | Lyophilized powder, glass vial |
| Purity target | ≥ 99% by HPLC |
| Vial formats | 5 mg, 10 mg, 15 mg, 20 mg |
| Documentation | Batch-linked COA + HPLC chromatogram + MS identity record for every production lot |
| Distribution scope | Research use, worldwide |
| Storage | 2–8 °C protected from light; long-term −20 °C |
MOQ & lead time
| Tier | Quantity | Lead time |
|---|---|---|
| Sample lot | From 100 vials | 5–10 days |
| Production lot | 500–2,000 vials | 14–21 days |
| OEM repeat | 2,000+ vials | 21–28 days, scheduled |
All retatrutide quotes require a destination country and buyer track. Inquiries from US regulated facilities are answered with the regulatory bulk-substance framework proposal and routed to non-GLP-1 alternatives.
Documentation
Every Retatrutide lot ships with a batch document pack for the production lot.
COA, HPLC chromatogram, MS identity confirmation, water content and storage notes. Buyer track and destination confirmed before invoicing.
MS identity
Mass spectrometry identity confirmation against the Retatrutide reference profile.
Lot traceability
Lot code printed on vial label and reflected in the document pack. Reorders cite the prior lot for continuity.
FAQ
Common Retatrutide questions from B2B buyers.
How is retatrutide supplied?
On 2026-04-30 the FDA proposed removing GLP-1 medications from the regulatory bulk-substance framework. While retatrutide itself is the target of separate clinical-stage development, Pepti supplies it as a research peptide worldwide for research and private-label brand evaluation; buyers confirm local compliance.
Which markets do you serve for retatrutide?
Latin America, Southeast Asia, parts of the Middle East, and select EMEA distributors with appropriate local registration.
Can research labs source retatrutide?
Yes — lyophilized retatrutide is supplied for laboratory research with COA, HPLC, and MS. Research inquiries are reviewed before quoting.
What is the MOQ?
Sample lots from 100 vials; production lots from 500 vials with tier pricing.
What does your COA report?
HPLC purity (target ≥99%), MS identity, water content, related-substance profile on request, and lot traceability tied to the document pack.
Related compounds